What regions does the Leishmaniasis Treatment market report cover?

The report covers the Leishmaniasis Treatment market across Global, including detailed regional breakdowns, forecasts, and competitive analysis.

Leishmaniasis Treatment Market Potential & Strategic Outlook 2033

Leishmaniasis Treatment by Application (/> Visceral Leishmaniasis, Cutaneous Leishmaniasis), by Type (/> Meglumine Antimoniate, Pentamidine, Hydroxyl Amidine Stilbene, Amphotericin B), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $18 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $18 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

11 items

1. Executive Summary

2. Leishmaniasis Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Leishmaniasis Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Leishmaniasis Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. /> Visceral Leishmaniasis

6.1.2. Cutaneous Leishmaniasis

6.2. Global Leishmaniasis Treatment Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. /> Meglumine Antimoniate

6.2.2. Pentamidine

6.2.3. Hydroxyl Amidine Stilbene

6.2.4. Amphotericin B

6.3. Global Leishmaniasis Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Leishmaniasis Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Leishmaniasis Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Leishmaniasis Treatment Market Competition by Key Manufacturers

8.1. Global Leishmaniasis Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Leishmaniasis Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. iCo Therapeutics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. AEterna Zentaris

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. AEterna Zentaris AG

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Eurofins Advinus

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Pieris Pharmaceuticals

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Dafra Pharma

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Leishmaniasis Treatment Market

Figure 4: Global Leishmaniasis Treatment Market: Drivers

Figure 5: Global Leishmaniasis Treatment Market: Challenges

Figure 6: Global Leishmaniasis Treatment Market: Trends

Figure 7: Global Leishmaniasis Treatment Market: Opportunity

Figure 8: Global Leishmaniasis Treatment Market: Restraint

Figure 9: Global Leishmaniasis Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Leishmaniasis Treatment Market Value (USD Million) By Region

Figure 15: Global Leishmaniasis Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Leishmaniasis Treatment Market Value (USD Million) By Region

Figure 23: Global Leishmaniasis Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Leishmaniasis Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Leishmaniasis Treatment Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Leishmaniasis Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Leishmaniasis Treatment Market Value (USD Million) By Region

Table 10: Global Leishmaniasis Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Leishmaniasis Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Leishmaniasis Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Leishmaniasis Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck Basic Information And Sales Area

Table 31: Merck. Products Portfolio

Table 32: iCo Therapeutics Basic Information And Sales Area

Table 33: iCo Therapeutics. Products Portfolio

Table 34: AEterna Zentaris Basic Information And Sales Area

Table 35: AEterna Zentaris. Products Portfolio

Table 36: AEterna Zentaris AG Basic Information And Sales Area

Table 37: AEterna Zentaris AG. Products Portfolio

Table 38: Eurofins Advinus Basic Information And Sales Area

Table 39: Eurofins Advinus. Products Portfolio

Table 40: Pieris Pharmaceuticals Basic Information And Sales Area

Table 41: Pieris Pharmaceuticals. Products Portfolio

Table 42: Dafra Pharma Basic Information And Sales Area

Table 43: Dafra Pharma. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Type

Table 47: Global Market Share (%) By Type (2032)

Table 48: Global Leishmaniasis Treatment Market Value (USD Million) By Region

Table 49: Global Leishmaniasis Treatment Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Type

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Type

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Type

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the Leishmaniasis Treatment?

The projected CAGR is approximately 4.2.

2. Which companies are prominent players in the Leishmaniasis Treatment?

Key companies in the market include Merck, iCo Therapeutics, AEterna Zentaris, AEterna Zentaris AG, Eurofins Advinus, Pieris Pharmaceuticals, Dafra Pharma.

3. What are the main segments of the Leishmaniasis Treatment?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be 18

5. What are some drivers contributing to market growth?

Increasing Demand for Various Applications to Aid Market Growth.

6. What are the notable trends driving market growth?

Increasing Demand for Various Applications to Aid Market Growth.

7. Are there any restraints impacting market growth?

Increasing Demand for Various Applications to Aid Market Growth.

8. Can you provide examples of recent developments in the market?

Recent developments data is not available.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in 18.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Leishmaniasis Treatment," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Leishmaniasis Treatment report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided with the report for further details.

14. How can I stay updated on further developments or reports in the Leishmaniasis Treatment?

To stay informed about further developments, trends, and reports in the Leishmaniasis Treatment, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Contact for Full Report

Loading report content...

Table of Contents